479 related articles for article (PubMed ID: 17724844)
1. Chronic hepatitis B: a wider range of therapeutic options.
Prescrire Int; 2007 Aug; 16(90):157-62. PubMed ID: 17724844
[TBL] [Abstract][Full Text] [Related]
2. Adefovir dipivoxil: new preparation. A third-line option in chronic hepatitis B.
Prescrire Int; 2004 Feb; 13(69):4-7. PubMed ID: 15055205
[TBL] [Abstract][Full Text] [Related]
3. Entecavir: new drug. Chronic hepatitis B: a last resort.
Prescrire Int; 2007 Oct; 16(91):183-5. PubMed ID: 17926822
[TBL] [Abstract][Full Text] [Related]
4. Treatment of chronic hepatitis B: interferon alfa first.
Prescrire Int; 2001 Feb; 10(51):17-21. PubMed ID: 11503853
[TBL] [Abstract][Full Text] [Related]
5. Entecavir: a new nucleoside analog for the treatment of chronic hepatitis B infection.
Sims KA; Woodland AM
Pharmacotherapy; 2006 Dec; 26(12):1745-57. PubMed ID: 17125436
[TBL] [Abstract][Full Text] [Related]
6. A review of entecavir in the treatment of chronic hepatitis B infection.
Rivkin A
Curr Med Res Opin; 2005 Nov; 21(11):1845-56. PubMed ID: 16307706
[TBL] [Abstract][Full Text] [Related]
7. Entecavir for chronic hepatitis B: a review.
Palumbo E
Ther Drug Monit; 2008 Feb; 30(1):1-4. PubMed ID: 18223455
[TBL] [Abstract][Full Text] [Related]
8. Adefovir dipivoxil in the treatment of chronic hepatitis B.
Rivkin AM
Ann Pharmacother; 2004 Apr; 38(4):625-33. PubMed ID: 14990784
[TBL] [Abstract][Full Text] [Related]
9. Selection of an entecavir-resistant mutant despite prolonged hepatitis B virus DNA suppression, in a chronic hepatitis B patient with preexistent lamivudine resistance: successful rescue therapy with tenofovir.
Leemans WF; Niesters HG; van der Eijk AA; Janssen HL; Schalm SW; de Man RA
Eur J Gastroenterol Hepatol; 2008 Aug; 20(8):773-7. PubMed ID: 18617782
[TBL] [Abstract][Full Text] [Related]
10. Results of up to 2 years of entecavir vs lamivudine therapy in nucleoside-naïve HBeAg-positive patients with chronic hepatitis B.
Chang TT; Chao YC; Gorbakov VV; Han KH; Gish RG; de Man R; Cheinquer H; Bessone F; Brett-Smith H; Tamez R
J Viral Hepat; 2009 Nov; 16(11):784-9. PubMed ID: 19457141
[TBL] [Abstract][Full Text] [Related]
11. Entecavir: a new treatment option for chronic hepatitis B.
Zoulim F
J Clin Virol; 2006 May; 36(1):8-12. PubMed ID: 16515882
[TBL] [Abstract][Full Text] [Related]
12. Chronic hepatitis B--treatment with nucleoside analogues.
Leung N
Med J Malaysia; 2005 Jul; 60 Suppl B():22-7. PubMed ID: 16108169
[TBL] [Abstract][Full Text] [Related]
13. Treatment alternatives for hepatitis B cirrhosis: a cost-effectiveness analysis.
Kanwal F; Farid M; Martin P; Chen G; Gralnek IM; Dulai GS; Spiegel BM
Am J Gastroenterol; 2006 Sep; 101(9):2076-89. PubMed ID: 16968510
[TBL] [Abstract][Full Text] [Related]
14. Interferon/long-term lamivudine combination therapy in anti-HBe positive chronic hepatitis B patients.
Nikolaidis NL; Giouleme OI; Tziomalos KA; Saveriadis AS; Grammatikos N; Doukelis P; Voutsas AD; Vassiliadis T; Patsiaoura K; Orfanou-Koumerkeridou E; Balaska A; Eugenidis NP
J Gastroenterol Hepatol; 2005 Nov; 20(11):1721-5. PubMed ID: 16246192
[TBL] [Abstract][Full Text] [Related]
15. Treatment of chronic hepatitis B virus infection - Dutch national guidelines.
Buster EH; van Erpecum KJ; Schalm SW; Zaaijer HL; Brouwer JT; Gelderblom HC; de Knegt RJ; Minke Bakker C; Reesink HW; Janssen HL;
Neth J Med; 2008; 66(7):292-306. PubMed ID: 18663260
[TBL] [Abstract][Full Text] [Related]
16. [Treatment of chronic hepatitis B].
Marcellin P; Asselah T; Boyer N
Rev Prat; 2005 Mar; 55(6):624-32. PubMed ID: 15913114
[TBL] [Abstract][Full Text] [Related]
17. Entecavir for the treatment of chronic hepatitis B virus infection.
Matthews SJ
Clin Ther; 2006 Feb; 28(2):184-203. PubMed ID: 16678641
[TBL] [Abstract][Full Text] [Related]
18. One-year entecavir or lamivudine therapy results in reduction of hepatitis B virus intrahepatic covalently closed circular DNA levels.
Wong DK; Yuen MF; Ngai VW; Fung J; Lai CL
Antivir Ther; 2006; 11(7):909-16. PubMed ID: 17302253
[TBL] [Abstract][Full Text] [Related]
19. [New developments in therapy of chronic hepatitis B. When are nucleoside analogs indicated?].
Petry W; Erhardt A; Heintges T; Häussinger D
Z Gastroenterol; 2000 Jan; 38(1):77-87. PubMed ID: 10689749
[TBL] [Abstract][Full Text] [Related]
20. Randomised clinical trial: efficacy of peginterferon alfa-2a in HBeAg positive chronic hepatitis B patients with lamivudine resistance.
Sun J; Hou JL; Xie Q; Li XH; Zhang JM; Wang YM; Wang H; Lai JY; Chen SJ; Jia JD; Sheng JF; Chan HL; Wang JF; Li MK; Jiang M; Popescu M; Sung JJ
Aliment Pharmacol Ther; 2011 Aug; 34(4):424-31. PubMed ID: 21692822
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
